GGrantIndex
← Leaderboards

Jean Claire Lee

Brigham And Women'S Hospital

$9,102,521
Attributed
$10,478,864
Total exposure
9
Grants
3
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.2M · FY200521
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21

Funding mix

By agency

NIH$10,478,864 · 9

By mechanism

R01$9,600,226 · 5
R21$760,888 · 2
R03$102,750 · 1
R13$15,000 · 1

Top collaborators

Most similar at Brigham And Women'S Hospital

Same institution · by research overlap

Others in their field

Top investigators on “Staphylococcus Aureus

Research focus

Staphylococcus AureusLaboratory MouseInfectionProductionCommunitiesCellsAnimalsBaseBacterial CapsulesImmuneVirulenceAntibodiesSerumPreventBacteremiaPneumoniaVaccinesMethicillin ResistanceStaphylococcal InfectionsRodent ModelLifeNeutrophilProteinsPathogen

Grant awards (29)

Staphylococcus aureus extracellular vesicles: host-pathogen interactions$553,570
R01 · FY2021 · AI · contact PI
Staphylococcus aureus extracellular vesicles: host-pathogen interactions$543,170
R01 · FY2020 · AI · contact PI
Staphylococcus aureus extracellular vesicles: host-pathogen interactions$493,947
R01 · FY2019 · AI · contact PI
Development of a vesicle-based vaccine platform against Staphylococcus aureus$256,650
R21 · FY2019 · AI · contact PI
Development of a vesicle-based vaccine platform against Staphylococcus aureus$219,010
R21 · FY2018 · AI · contact PI
A New Approach to Staphylococcus aureus Vaccine Development - Resubmission 01$264,133
R01 · FY2016 · AI
A New Approach to Staphylococcus aureus Vaccine Development - Resubmission 01$249,382
R01 · FY2016 · AI
A New Approach to Staphylococcus aureus Vaccine Development - Resubmission 01$517,000
R01 · FY2015 · AI
Novel Bioconjugate Vaccines to Prevent Staphylococcus aureus Infection$669,443
R01 · FY2014 · AI · contact PI
A New Approach to Staphylococcus aureus Vaccine Development - Resubmission 01$517,000
R01 · FY2014 · AI
Novel Bioconjugate Vaccines to Prevent Staphylococcus aureus Infection$626,908
R01 · FY2013 · AI · contact PI
A New Approach to Staphylococcus aureus Vaccine Development - Resubmission 01$517,000
R01 · FY2013 · AI
Novel Bioconjugate Vaccines to Prevent Staphylococcus aureus Infection$806,198
R01 · FY2012 · AI · contact PI
Novel Bioconjugate Vaccines to Prevent Staphylococcus aureus Infection$676,708
R01 · FY2011 · AI · contact PI
Novel Bioconjugate Vaccines to Prevent Staphylococcus aureus Infection$710,710
R01 · FY2010 · AI · contact PI
Genetic Analysis of S. aureus Capsule Production$327,427
R01 · FY2005 · AI
Biological relevance of capsule expression by S. aureus$32,000
R03 · FY2005 · TW
2005 Staphylococcal Diseases Gordon Research Conferences$15,000
R13 · FY2005 · AI
Genetic Analysis of S. aureus Capsule Production$327,872
R01 · FY2004 · AI
Biological relevance of capsule expression by S. aureus$32,000
R03 · FY2004 · TW
Genetic Analysis of S. aureus Capsule Production$328,300
R01 · FY2003 · AI
NASAL COLONIZATION BY S AUREUS--MECHANISMS AND IMMUNITY$259,935
R01 · FY2003 · AI
Biological relevance of capsule expression by S. aureus$38,750
R03 · FY2003 · TW
Genetic Analysis of S. aureus Capsule Production$328,712
R01 · FY2002 · AI
NASAL COLONIZATION BY S AUREUS--MECHANISMS AND IMMUNITY$252,393
R01 · FY2002 · AI
NASAL COLONIZATION BY S AUREUS--MECHANISMS AND IMMUNITY$231,645
R01 · FY2001 · AI
Genetic Analysis of S. aureus Capsule Production$173,845
R01 · FY2001 · AI
GENETIC ANALYSIS OF S. AUREUS CAPSULE PRODUCTION$285,228
R21 · FY2000 · AI
NASAL COLONIZATION BY S AUREUS--MECHANISMS AND IMMUNITY$224,928
R01 · FY2000 · AI